Skip to main content

Advertisement

SpringerLink
Log in

Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)

  • ORIGINAL ARTICLE
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Macrophage colony-stimulating factor (M-CSF) is a key factor for osteoclastogenesis at the bone–pannus interface in patients with rheumatoid arthritis as well as a receptor activator of NF-κB ligand (RANKL). Imatinib mesylate inhibits the phosphorylation of c-fms, a receptor for M-CSF. The present study investigates the effect of imatinib mesylate on joint destruction in rats with collagen-induced arthritis (CIA) and on osteoclastogenesis in vitro. Imatinib mesylate (50 or 150 mg/kg), dexamethasone, or vehicle was administered daily to CIA rats for 4 weeks from the onset of arthritis. Hind-paw swelling and body weight were measured weekly. At weeks 2 and 4, the metatarsophalangeal (MTP) joints and the ankle and subtalar joints were radiographically and histologically assessed. The effect of imatinib mesylate on osteoclast formation from rat bone marrow cells with M-CSF and soluble RANKL (sRANKL) in vitro was also examined. Radiographic assessment showed that 150 mg/kg imatinib mesylate suppressed the destruction of the MTP and the ankle and subtalar joints at week 2, and MTP joint destruction at week 4 in CIA rats, although hind-paw swelling was not suppressed. The number of TRAP-positive cells at the bone–pannus interface was significantly reduced in the group administered with 150 mg/kg imatinib mesylate compared with that given vehicle at week 4. Imatinib mesylate dose-dependently inhibited the proliferation of M-CSF-dependent osteoclast precursor cells in vitro as well as osteoclast formation induced by M-CSF and sRANKL. These findings suggest that imatinib mesylate could prevent joint destruction in patients with rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. SR Goldring EM Gravallese (2000) ArticleTitlePathogenesis of bone erosions in rheumatoid arthritis Curr Opin Rheumatol 12 195–199 Occurrence Handle10803748 Occurrence Handle10.1097/00002281-200005000-00006 Occurrence Handle1:STN:280:DC%2BD3c3mtVyqsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  2. BJ Druker S Tamura E Buchdunger S Ohno GM Segal et al. (1996) ArticleTitleEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 2 561–566 Occurrence Handle8616716 Occurrence Handle10.1038/nm0596-561 Occurrence Handle1:CAS:528:DyaK28Xislyhs70%3D

    Article  PubMed  CAS  Google Scholar 

  3. MC Heinrich DJ Griffith BJ Druker CL Wait KA Ott et al. (2000) ArticleTitleInhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor Blood 96 925–932 Occurrence Handle10910906 Occurrence Handle1:CAS:528:DC%2BD3cXltlKitLw%3D

    PubMed  CAS  Google Scholar 

  4. E Buchdunger CL Cioffi N Law D Stover S Ohno-Jones et al. (2000) ArticleTitleAbl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors J Pharmacol Exp Ther 295 139–145 Occurrence Handle10991971 Occurrence Handle1:CAS:528:DC%2BD3cXnt1ygur4%3D

    PubMed  CAS  Google Scholar 

  5. DA Tuveson NA Willis T Jacks JD Griffin S Singer et al. (2001) ArticleTitleSTI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications Oncogene 20 5054–5058 Occurrence Handle11526490 Occurrence Handle10.1038/sj.onc.1204704 Occurrence Handle1:CAS:528:DC%2BD3MXmtlCks7g%3D

    Article  PubMed  CAS  Google Scholar 

  6. K Miyachi A Ihara RW Hankins R Murai S Maehiro et al. (2003) ArticleTitleEfficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia Clin Rheumatol 22 329–332 Occurrence Handle14576993 Occurrence Handle10.1007/s10067-003-0716-3 Occurrence Handle1:STN:280:DC%2BD3svpvVOkuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  7. KK Eklund H Joensuu (2003) ArticleTitleTreatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases Ann Med 35 362–367 Occurrence Handle12952023 Occurrence Handle10.1080/07853890310001339 Occurrence Handle1:CAS:528:DC%2BD3sXmtVeltrk%3D

    Article  PubMed  CAS  Google Scholar 

  8. AL Dewar AC Cambareri AC Zannettino BL Miller KV Doherty et al. (2005) ArticleTitleMacrophage colony stimulating factor receptor, c-fms, is a novel target of imatinib Blood 105 3127–3132 Occurrence Handle15637141 Occurrence Handle10.1182/blood-2004-10-3967 Occurrence Handle1:CAS:528:DC%2BD2MXjtlSmur0%3D

    Article  PubMed  CAS  Google Scholar 

  9. FP van de Wijngaert MC Tas EH Burger (1989) ArticleTitleConditioned medium of fetal mouse long bone rudiments stimulates the formation of osteoclast precursor-like cells from mouse bone marrow Bone (NY) 10 61–68 Occurrence Handle1:STN:280:DyaL1M3oslWksQ%3D%3D

    CAS  Google Scholar 

  10. R Felix MG Cecchini W Hofstetter PR Elford A Stutzer (1990) ArticleTitleImpairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse J Bone Miner Res 5 781–789 Occurrence Handle2204254 Occurrence Handle1:CAS:528:DyaK3MXksF2q Occurrence Handle10.1002/jbmr.5650050716

    Article  PubMed  CAS  Google Scholar 

  11. H Kodama A Yamasaki M Nose S Niida Y Ohgame et al. (1991) ArticleTitleCongenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor J Exp Med 173 269–272 Occurrence Handle1985123 Occurrence Handle10.1084/jem.173.1.269 Occurrence Handle1:CAS:528:DyaK3MXnvFymsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  12. S Tanaka N Takahashi N Udagawa T Tamura T Akatsu et al. (1993) ArticleTitleMacrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors J Clin Invest 91 257–263 Occurrence Handle8423223 Occurrence Handle1:CAS:528:DyaK3sXhs1WltLs%3D

    PubMed  CAS  Google Scholar 

  13. H Yasuda N Shima N Nakagawa K Yamaguchi M Kinosaki et al. (1998) ArticleTitleOsteoclast differentiation factor is a ligand for osteoprotegerin /osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci U S A 95 3597–3602 Occurrence Handle9520411 Occurrence Handle10.1073/pnas.95.7.3597 Occurrence Handle1:CAS:528:DyaK1cXitlKjsLY%3D

    Article  PubMed  CAS  Google Scholar 

  14. T Suda N Takahashi N Udagawa E Jimi MT Gillespie et al. (1999) ArticleTitleModulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 345–357 Occurrence Handle10368775 Occurrence Handle10.1210/er.20.3.345 Occurrence Handle1:CAS:528:DyaK1MXktVaqtLg%3D

    Article  PubMed  CAS  Google Scholar 

  15. N Udagawa N Takahashi E Jimi K Matsuzaki T Tsurukai et al. (1999) ArticleTitleOsteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand Bone (NY) 25 517–523 Occurrence Handle1:CAS:528:DyaK1MXmvVKju78%3D

    CAS  Google Scholar 

  16. DD Wood EJ Ihrie D Hamerman (1985) ArticleTitleRelease of interleukin-1 from human synovial tissue in vitro Arthritis Rheum 28 853–862 Occurrence Handle3875350 Occurrence Handle1:CAS:528:DyaL2MXlsFyrsb4%3D

    PubMed  CAS  Google Scholar 

  17. PA Guerne BL Zuraw JH Vaughan DA Carson M Lotz (1989) ArticleTitleSynovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis J Clin Invest 83 585–592 Occurrence Handle2464001 Occurrence Handle1:CAS:528:DyaL1MXhtFaru70%3D Occurrence Handle10.1172/JCI113921

    Article  PubMed  CAS  Google Scholar 

  18. C Ritchlin (2000) ArticleTitleFibroblast biology. Effector signals released by the synovial fibroblast in arthritis Arthritis Res 2 356–360 Occurrence Handle11094448 Occurrence Handle10.1186/ar112 Occurrence Handle1:CAS:528:DC%2BD3cXmtVaqu7k%3D

    Article  PubMed  CAS  Google Scholar 

  19. H Takayanagi H Iizuka T Juji T Nakagawa A Yamamoto et al. (2000) ArticleTitleInvolvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis Arthritis Rheum 43 259–269 Occurrence Handle10693864 Occurrence Handle10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W Occurrence Handle1:CAS:528:DC%2BD3cXhs1aqtLw%3D

    Article  PubMed  CAS  Google Scholar 

  20. H Tsuboi N Udagawa J Hashimoto H Yoshikawa N Takahashi et al. (2005) ArticleTitleNurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage-colony stimulating factor production Arthritis Rheum 52 3819–3828 Occurrence Handle16320327 Occurrence Handle10.1002/art.21425 Occurrence Handle1:CAS:528:DC%2BD28XjvF2itg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  21. DE Trentham AS Townes AH Kang (1977) ArticleTitleAutoimmunity to type II collagen: an experimental model of arthritis J Exp Med 146 857–868 Occurrence Handle894190 Occurrence Handle10.1084/jem.146.3.857 Occurrence Handle1:STN:280:DyaE2s3ltFejtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  22. M Nishikawa A Myoui T Tomita K Takahi A Nampei et al. (2003) ArticleTitlePrevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653 Arthritis Rheum 48 2670–2681 Occurrence Handle13130488 Occurrence Handle10.1002/art.11227 Occurrence Handle1:CAS:528:DC%2BD3sXot1WjtL4%3D

    Article  PubMed  CAS  Google Scholar 

  23. S Cuzzocrea E Mazzon L Dugo I Serraino D Britti et al. (2001) ArticleTitleAbsence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis Eur Cytokine Netw 12 568–580 Occurrence Handle11781183 Occurrence Handle1:CAS:528:DC%2BD38Xht1SksbY%3D

    PubMed  CAS  Google Scholar 

  24. K Kobayashi N Takahashi E Jimi N Udagawa M Takami et al. (2000) ArticleTitleTumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J Exp Med 191 275–286 Occurrence Handle10637272 Occurrence Handle10.1084/jem.191.2.275 Occurrence Handle1:CAS:528:DC%2BD3cXntFenug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  25. JR Kirwan (1995) ArticleTitleThe effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group N Engl J Med 333 142–146 Occurrence Handle7791815 Occurrence Handle10.1056/NEJM199507203330302 Occurrence Handle1:STN:280:DyaK2Mzht1Sjuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  26. HE Paulus D Di Primeo M Sanda JM Lynch BA Schwartz et al. (2000) ArticleTitleProgression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis J Rheumatol 27 1632–1637 Occurrence Handle10914843 Occurrence Handle1:CAS:528:DC%2BD3cXltlKqsLw%3D

    PubMed  CAS  Google Scholar 

  27. SL Perkins SJ Kling (1995) ArticleTitleLocal concentrations of macrophage colony-stimulating factor mediate osteoclastic differentiation Am J Physiol 269 1024–1030

    Google Scholar 

  28. E Takeuchi T Tomita T Toyosaki-Maeda M Kaneko H Takano et al. (1999) ArticleTitleEstablishment and characterization of nurse cell-like stromal cell lines from synovial tissues of patients with rheumatoid arthritis Arthritis Rheum 42 221–228 Occurrence Handle10025915 Occurrence Handle10.1002/1529-0131(199902)42:2<221::AID-ANR3>3.0.CO;2-N Occurrence Handle1:CAS:528:DyaK1MXhtlars78%3D

    Article  PubMed  CAS  Google Scholar 

  29. T Tomita E Takeuchi T Toyosaki-Maeda H Oku M Kaneko et al. (1999) ArticleTitleEstablishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis Rheumatology (Oxf) 38 854–863 Occurrence Handle10.1093/rheumatology/38.9.854 Occurrence Handle1:STN:280:DyaK1MvktlKksg%3D%3D

    Article  CAS  Google Scholar 

  30. AL Dewar RM Domaschenz KV Doherty TP Hughes AB Lyons (2003) ArticleTitleImatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors Leukemia 17 1713–1721 Occurrence Handle12970769 Occurrence Handle10.1038/sj.leu.2403071 Occurrence Handle1:CAS:528:DC%2BD3sXntFChsrw%3D

    Article  PubMed  CAS  Google Scholar 

  31. Y Matsumoto K Tanaka G Hirata M Hanada S Matsuda et al. (2002) ArticleTitlePossible involvement of the vascular endothelial growth factor-Flt-1–focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints J Immunol 168 5824–5831 Occurrence Handle12023386 Occurrence Handle1:CAS:528:DC%2BD38XktFCrt7c%3D

    PubMed  CAS  Google Scholar 

  32. K Pietras A Ostman M Sjoquist E Buchdunger RK Reed et al. (2001) ArticleTitleInhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors Cancer Res 61 2929–2934 Occurrence Handle11306470 Occurrence Handle1:CAS:528:DC%2BD3MXivFGqsro%3D

    PubMed  CAS  Google Scholar 

  33. E Buchdunger CL Cioffi N Law D Stover S Ohno-John et al. (2000) ArticleTitleAbl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-sderived growth factor receptors J Pharmacol Exp Ther 295 139–145 Occurrence Handle10991971 Occurrence Handle1:CAS:528:DC%2BD3cXnt1ygur4%3D

    PubMed  CAS  Google Scholar 

  34. T Schindler W Bornmann P Pellicena WT Miller B Clarkson et al. (2000) ArticleTitleStructural mechanism for STI-571 inhibition of abelson tyrosine kinase Science 289 1938–1942 Occurrence Handle10988075 Occurrence Handle10.1126/science.289.5486.1938 Occurrence Handle1:CAS:528:DC%2BD3cXms1altLc%3D

    Article  PubMed  CAS  Google Scholar 

  35. T Miyazaki A Sanjay L Neff S Tanaka WC Horne et al. (2004) ArticleTitleSrc kinase activity is essential for osteoclast function J Biol Chem 279 17660–17666 Occurrence Handle14739300 Occurrence Handle10.1074/jbc.M311032200 Occurrence Handle1:CAS:528:DC%2BD2cXjt1Gntbo%3D

    Article  PubMed  CAS  Google Scholar 

  36. T Hirayama L Danks A Sabokbar NA Athanasou (2002) ArticleTitleOsteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis Rheumatology 41 1232–1239 Occurrence Handle12421995 Occurrence Handle10.1093/rheumatology/41.11.1232 Occurrence Handle1:CAS:528:DC%2BD38XosFOhu7o%3D

    Article  PubMed  CAS  Google Scholar 

  37. PW Tsao T Suzuki R Totsuka T Murata T Takagi et al. (1997) ArticleTitleThe effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis Clin Immunol Immunopathol 83 173–178 Occurrence Handle9143378 Occurrence Handle10.1006/clin.1997.4333 Occurrence Handle1:CAS:528:DyaK2sXjtFKms7k%3D

    Article  PubMed  CAS  Google Scholar 

  38. E Romas O Bakharevski DK Hards V Kartsogiannis JM Quinn et al. (2000) ArticleTitleExpression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis Arthritis Rheum 43 821–826 Occurrence Handle10765926 Occurrence Handle10.1002/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T Occurrence Handle1:CAS:528:DC%2BD3cXivFOitrs%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, 565-0871, Japan

    Wataru Ando, Jun Hashimoto, Akihide Nampei, Hideki Tsuboi, Kosuke Tateishi, Takeshi Ono, Norimasa Nakamura & Hideki Yoshikawa

  2. National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan

    Takahiro Ochi

Authors
  1. Wataru Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akihide Nampei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideki Tsuboi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kosuke Tateishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takeshi Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norimasa Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takahiro Ochi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hideki Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Hashimoto.

About this article

Cite this article

Ando, W., Hashimoto, J., Nampei, A. et al. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA). J Bone Miner Metab 24, 274–282 (2006). https://doi.org/10.1007/s00774-006-0684-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-006-0684-1

Key words

Search

Navigation